Loading data for SPRC — first visit, this takes a few seconds.
SciSparc Ltd. (SPRC)
NasdaqCM: SPRC
· 即時價格 · USD
5.29
-0.03 (-0.56%)
收盤價： Sep 04, 2026, 3:55 PM
股價、關鍵數字和最新消息，都在這一頁。
SciSparc Ltd.（SPRC）股價、分析與資料
-0.62% (1D)
| 買價 | 3.82 |
| 市值 | 3.07M |
| 營收 (ttm) | 856K |
| 淨利（ttm） | -12.2M |
| 2.44 | |
| 98.07 | |
| 0.05 | |
| n/a | |
| P/B (ttm) | 0.46 |
| P/S (ttm) | 142.59 |
| 財報日期 | n/a |
| 賣價 | 6.63 |
| 成交量 | 27,399 |
| 20 日平均成交量 | 189,595 |
| 開盤價 | 5.17 |
| 前收盤價 | 5.32 |
| 當日區間 | 5.15 - 5.43 |
| 52 週範圍 | 2.98 - 80.10 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 SPRC
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company sells hemp seed oil-based products and others. The company has an agre...
完整的公司簡介財報驚奇
SciSparc 已於 Invalid Date 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 低於預期 , 年增 NaN% 成長.
第 1 頁，共 2 頁